IL Believe
ClinicalTrials.gov NCT05081609
Research payments
$1,261,610
Through program year 2025, $1,261,610 in research payments was reported against IL Believe, across 143 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- NCT05081609
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $465,478 | 66 |
| 2024 | Research | $726,923 | 66 |
| 2023 | Research | $69,209 | 11 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Diwakar Davar Pittsburgh, PA Named on 33 payments
- Oladapo Yeku Boston, MA Named on 24 payments
- Alexander Starodub Cincinnati, OH Named on 17 payments
- June Hou New Haven, CT Named on 14 payments
- David Spigel Nashville, TN Named on 13 payments
- Andrew Poklepovic Richmond, VA Named on 12 payments
- Nashat Gabrail Canton, OH Named on 6 payments
- John Powderly Huntersville, NC Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.